Stock Information
Neurogene Inc (NGNE)
Ticker Symbol: NGNE
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $320.48 mil
Piotroski score: 3
Financial data not available
Latest News
-
Neurogene To Highlight ICV As Routine Neurosurgical Procedure Providing Broad Biodistribution Of Gene Therapy To Brain And Nervous System At ASGCT Meeting
Tue, Apr 28, 2026 7:36 AM
-
Neurogene Announces Upcoming Presentation on the Therapeutic Rationale for ICV Delivery in CNS-Targeted Gene Therapy
Tue, Apr 28, 2026 7:31 AM
Key Financials
Financial data not available
